Quick infos Headquarters: Rockville, Maryland, United States Trade prices Volume: Market Cap: 217.99M Prev closed: 2.85 Open: 2.84 High: 2.93 Low: 2.84 52 week low: 1.52 52 week high: 5.2 Dividends: No Dividends Next ER: November 12, 2020
Earnings History Date EPS / Forecast Revenue / Forecast March 17, 2021 November 9, 2020 -0.16 / -0.0951.11M / 1.5MAugust 17, 2020 - / -0.09- / 1.86MAugust 6, 2020 -0.18 / -0.111.34M / 2.25MMay 7, 2020 -0.36 / -0.12.75M / 1.84MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Jan 7, 2021 2.91 2.85 2.93
2.85
448.40K 2.11% Jan 6, 2021 2.85 2.85 3.01
2.81
575.23K -2.4% Jan 5, 2021 2.92 3.10 3.18
2.83
3.58M 10.61% Jan 4, 2021 2.64 2.66 2.66
2.57
152.89K 0% Dec 31, 2020 2.64 2.67 2.69
2.61
188.75K -2.94% Dec 30, 2020 2.72 2.71 2.73
2.67
114.54K -0.37% Dec 29, 2020 2.73 2.74 2.77
2.60
260.20K -0.73% Dec 28, 2020 2.75 2.79 2.80
2.71
226.37K 0% Dec 24, 2020 2.75 2.75 2.76
2.66
143.29K 0% Dec 23, 2020 2.75 2.72 2.81
2.68
237.08K 0% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Cerecor prices $36.4M stock and warrants offering seekingalpha.com Jan 8, 2021 12:34 pm Cerecor Inc. Announces Pricing of $36.4 Million Public ... globenewswire.com Jan 8, 2021 11:34 am
3 Penny Stocks That Could Climb Over 140% finance.yahoo.com Jan 8, 2021 9:49 am Cerecor Inc. - Consensus Indicates Potential 174.0% Upside directorstalkinterviews.com Jan 8, 2021 8:34 am
How Many Cerecor Inc. (NASDAQ:CERC) Shares Do Institutions Own? finance.yahoo.com Jan 8, 2021 7:47 am
Cerecor Announces Peer-Reviewed Publication Highlighting the Role of the Inflammatory Cytokine, LIGHT, in COVID-19 ARDS finance.yahoo.com Jan 8, 2021 7:00 am
Cerecor Inc. Just Released Its Yearly Earnings: Here's What Analysts Think finance.yahoo.com Jan 8, 2021 6:59 am
Cerecor Announces Positive Phase I Safety Data for CERC-801 in Healthy Volunteers finance.yahoo.com Jan 8, 2021 6:30 am
Cerecor Added to Russell 3000® Index finance.yahoo.com Jan 8, 2021 6:30 am Snowflake Rally Defies End of Lockup on Millions of Shares ca.finance.yahoo.com Jan 8, 2021 5:34 am Cerecor slumps 12% on stock and pre-funded warrants offering seekingalpha.com Jan 8, 2021 5:16 am Should Cerecor Inc (CERC) be in Your Portfolio? investorsobserver.com Jan 7, 2021 1:34 pm Dissecting Cerecor Inc. (NASDAQ: CERC) top performing stock: Get the Stats newsrts.com Jan 7, 2021 1:34 pm Analysts Offer Insights on Healthcare Companies: NuVasive (NASDAQ: NUVA) and Cerecor (NASDAQ: CERC) analystratings.com Jan 7, 2021 1:34 pm How Will the Market React to Cerecor Inc (CERC) Stock Getting a Neutral Rating investorsobserver.com Jan 6, 2021 1:34 pm Cerecor gains on CERC-002 data in mid-stage COVID-19 study seekingalpha.com Jan 5, 2021 11:22 pm
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data finance.yahoo.com Jan 5, 2021 8:38 am Should You Buy Cerecor Inc (CERC) Stock on Tuesday? investorsobserver.com Dec 25, 2020 1:34 pm
Is CERC A Good Stock To Buy Now? finance.yahoo.com Dec 10, 2020 11:32 pm This company doesn't provide a dividend.
Key Persons CEO : Michael F. Cola CFO : Joe Miller Talk about Cerecor below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis